World Vaccine Congress Washington 2025 introduction
World Vaccine Congress Washington 2025 is one of the most influential events in the global vaccine industry. It will be held at the Walter E. Washington Convention Center in Washington, D.C., from April 21 to 24, 2025. As a professional exchange platform in the vaccine field, this conference brings together vaccine experts from industry, academia, non-profit organizations and government agencies to discuss industry challenges and success experiences. The conference covers a variety of topics such as vaccine development, clinical trials, cancer immunotherapy, supply chain management and market access, involving key areas such as infectious diseases, cancer vaccines, veterinary vaccines and emerging diseases. Through four days of 1-on-1 networking activities, participants can communicate directly with thousands of vaccine experts, obtain the latest technical developments and establish cooperative relationships. For more information, please visit the official website.
Event and Booth Information
Join Us at World Vaccine Congress Washington 2025
- Date: 21 - 24 April，2025
- Location: Walter E. Washington Convention Center, Washington D.C.
- Booth Number: Visit us at Booth 513
We warmly invite you to visit our booth to explore our latest products and services. Our team will be available to discuss how Yeasen Biology can support your vaccine development needs.
Featured Products
LZCap AG (3'Acm) GMP-Grade, High Affinity (100mM) - 10684ES
A cutting-edge capping agent designed for mRNA synthesis, serving as a critical tool in vaccine development. With high-affinity capping properties, it significantly enhances mRNA stability and translation efficiency. Its GMP-grade quality ensures consistency and reliability, meeting the stringent standards of vaccine production. By enabling stable and efficient mRNA, LZCap AG (3'Acm) accelerates next-generation vaccine development, making it indispensable for researchers and manufacturers.
CleaScrip™ T7 RNA Polymerase (low dsRNA, 250 U/μL) - 10628ES
A revolutionary in vitro transcription enzyme engineered to minimize double-stranded RNA (dsRNA) byproducts. This feature is vital in vaccine development, as dsRNA can trigger adverse immune responses. With high concentration and purity, CleaScrip™ T7 RNA Polymerase ensures efficient and clean RNA synthesis, streamlining mRNA vaccine production. Its low-dsRNA profile enhances the safety and efficacy of vaccine candidates, making it a top choice for cutting-edge research.
UCF.ME UltraNuclease GMP-grade (250 U/μL) - 20157ES
A genetically engineered endonuclease designed to digest all forms of DNA and RNA into oligonucleotides, making it an essential tool in vaccine manufacturing and virus purification. Produced under GMP conditions, this nuclease reduces host nucleic acid residues to pg-grade levels, ensuring the safety and performance of biological products. Its applications extend to protein research, where it reduces viscosity in cell lysates and enhances purification efficiency. With its high purity and reliability, UCF.ME UltraNuclease supports stringent quality control in vaccine production, making it a critical component for manufacturers aiming to meet regulatory standards.
Hieff Trans™ Ultra PEI AAV Transfection Reagent - 40823ES
A linearized polyethyleneimine (PEI) transfection reagent specifically developed for large-scale AAV production in suspension culture systems. This chemically synthesized, animal-origin-free reagent offers low cytotoxicity and high stability, making it ideal for vaccine and gene therapy applications. With broad compatibility across various AAV serotypes and a strong DNA loading capacity, it streamlines the production process while maintaining high transfection efficiency. Provided in a sterile liquid form, Hieff Trans™ Ultra PEI AAV Transfection Reagent is a versatile solution for researchers and manufacturers seeking scalable, reliable AAV production for vaccine development.
Discover how Yeasen Biology can accelerate your vaccine development journey. Visit us at Booth 513 to learn more about our innovative solutions!
Additional Information
For more details, visit the World Vaccine Congress Washington 2025.
Contact Us:
Website: www.yeasenbio.com
Email: info@yeasenbio.com